Skip to content
BiologicalX

Comparison

Coenzyme Q10 vs Vitamin D3 + K2

Side-by-side of Coenzyme Q10 and Vitamin D3 + K2. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Coenzyme Q10

  • Q-SYMBIO trial showed 43% reduction in major cardiovascular events at 300 mg/day in heart failure
  • Reduces statin-induced myalgia in some patients at 100-200 mg/day per Banach 2014 meta-analysis
  • Migraine prophylaxis at 300 mg/day daily; AHS lists at Level B for prevention
  • Ubiquinol absorbs 2-3x better than ubiquinone in adults over 60
  • Plasma CoQ10 falls 15-40% with chronic statin therapy
  • Small blood pressure reduction (3-5 mmHg systolic) at 100-200 mg/day

Vitamin D3 + K2

  • Reduces non-vertebral fractures 10-20% in older adults at 800 IU/day or above when combined with calcium
  • VITAL trial showed neutral results on primary CV and cancer endpoints at 2000 IU/day over 5 years
  • Vitamin D supplementation reduces respiratory infection incidence ~10-20% in deficient populations
  • K2 MK-7 has 72-hour plasma half-life vs 1-2 hours for MK-4; once-daily dosing is sufficient
  • Synergy hypothesis is largely preclinical; dedicated combination RCTs are limited
  • Daily dosing outperforms bolus dosing for immune and infection outcomes

Side-by-side

Attribute Coenzyme Q10 Vitamin D3 + K2
Category supplement supplement
Also known as CoQ10, ubiquinone, ubiquinol, Q10 cholecalciferol + menaquinone, D3/K2, vitamin D3 with MK-7
Half-life (hr) 34 360
Typical dose (mg) 200 0.05
Dosing frequency 1 to 3 times daily with a fat-containing meal daily with a fat-containing meal
Routes oral oral
Onset (hr) 6 24
Peak (hr) 720 168
Molecular weight 863.36 384.64
Molecular formula C59H90O4 C27H44O (D3); C46H64O2 (MK-7)
Mechanism Mobile electron carrier between Complex I/II and Complex III of the mitochondrial electron transport chain. Ubiquinol form acts as a lipid-soluble antioxidant in cell membranes and regenerates oxidized vitamin E. D3 converts to calcidiol then calcitriol, activating the vitamin D receptor (VDR) to increase intestinal calcium absorption and modulate immune and bone gene transcription. K2 carboxylates osteocalcin and matrix Gla protein, directing calcium toward bone and inhibiting vascular calcification.
Legal status Dietary supplement (most jurisdictions); prescription cardiac medication in Japan Dietary supplement (global)
WADA status allowed allowed
DEA / Rx Not scheduled Not scheduled
Pregnancy Limited safety data; precautionary use at standard doses Recommended at standard doses for fetal bone development; consult clinician at higher doses
CAS 303-98-0 67-97-0
PubChem CID 5281915 5280795
Wikidata Q140453 Q139347

Safety profile

Coenzyme Q10

Common side effects

  • mild GI upset (rare)
  • headache (rare)
  • insomnia at very high doses

Contraindications

  • active warfarin therapy without monitoring (modest interaction with INR)

Interactions

  • warfarin: structural similarity to vitamin K may modestly reduce warfarin efficacy; monitor INR(moderate)
  • antihypertensives: additive blood pressure-lowering at high doses(minor)
  • statins: statins reduce CoQ10 synthesis; CoQ10 supplementation does not affect statin efficacy(minor)
  • chemotherapy (oxidative-stress-dependent agents): theoretical interference; coordinate with oncology team(moderate)

Vitamin D3 + K2

Common side effects

  • GI upset at high doses
  • headache (rare)
  • hypercalcemia (only at sustained very high D3 doses)

Contraindications

  • hypercalcemia
  • sarcoidosis
  • active hyperparathyroidism
  • warfarin therapy (K2 component requires stable intake)

Interactions

  • warfarin: K2 component can affect anticoagulation; maintain stable intake and inform anticoagulation clinic(moderate)
  • thiazide diuretics: additive calcium retention; hypercalcemia risk with high-dose D3(moderate)
  • digoxin and calcium channel blockers: additive effects from D3-induced hypercalcemia(moderate)
  • glucocorticoids: reduced vitamin D efficacy and bone effects(moderate)
  • cholestyramine and orlistat: bind fat-soluble vitamins; separate dosing by 2 to 4 hours(moderate)

Which Should You Take?

Coenzyme Q10 and Vitamin D3 + K2 score evenly on the criteria we weight (goal breadth, legal accessibility, evidence depth). The conditionals below should drive the decision more than any aggregate score.

Edge case: Half-lives differ materially (Coenzyme Q10 ~34 hr vs Vitamin D3 + K2 ~360 hr). Vitamin D3 + K2 reaches steady state faster; Coenzyme Q10 is easier to dial in if tolerability is uncertain.

Default choice: either is defensible. Coenzyme Q10 edges out on goal breadth + legal accessibility; Vitamin D3 + K2 is the right call if your priority sits in the goals listed above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Coenzyme Q10 and Vitamin D3 + K2?

Coenzyme Q10 and Vitamin D3 + K2 differ in category (supplement vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Coenzyme Q10 or Vitamin D3 + K2?

Coenzyme Q10 half-life is 34 hours; Vitamin D3 + K2 half-life is 360 hours.

Can you stack Coenzyme Q10 with Vitamin D3 + K2?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper